All News
Filter News
Found 71,907 articles
-
Vuzix Receives Additional Smart Glasses Order from 1Minuut Innovation in Response to COVID-19 Remote Healthcare Needs in the Netherlands
4/7/2020
Vuzix and 1Minuut Innovation to host a webinar to discuss COVID-19 virtual patient telemedicine care and training use cases
-
Honduras Air Force transported to Central America and Dominican Republic coronavirus screening tests donated by CABEI
4/7/2020
The President of Honduras, Juan Orlando Hernández, instructed the Air Force to transport and deliver to the Central American nations and Dominican Republic 182,000 COVID-19 rapid test kits donated by the Central American Bank for Economic Integration.
-
Martin's Point Health Care Is Maine's First Recipient of New Rapid COVID-19 Test
4/7/2020
Abbott Labs, the developer of a new rapid COVID-19 test, has delivered their first 1000 tests to Martin's Point Health Care, its largest customer in Maine.
-
Canadian Company STEMCELL Technologies Is an Essential Industry Partner for COVID-19 Research and Vaccine Development
4/7/2020
Products made by Vancouver’s STEMCELL Technologies are now being used in over 30 COVID-19 studies worldwide.
-
Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure
4/7/2020
All treated patients were in Intensive Care Units (ICU) on ventilators and suffered from Acute Respiratory Distress Syndrome (ARDS)
-
EmphyCorp N115 News: Reducing the Rate and Spread of COVID-19 with Nasal Nitric Oxide
4/7/2020
As cited in hundreds of peer reviewed publications, naturally occurring nitric oxide in the nasal cavities is a primary defense in humans that is needed to kill invading bacteria, fungi and viruses.
-
CROMSOURCE Announces Launch of COVID-19 Clinical Trial
4/7/2020
CROMSOURCE, an international contract research organization with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
-
Global Flu Vaccine Supplies May Fall Short With On-Going COVI-19 Transport Restrictions; Growing Demand Will Have Positive Long-Term Impact, Says PMR
4/7/2020
The initial projections for the flu vaccine market to reach US$8Bn by the end of 2029, is now projected to escalate even higher with the rapidly growing crisis of COVID-19.
-
Small Vaccine Market Projected to Gain Momentum in Future, Buoyed By Developments During COVID-19 Pandemic, Says PMR
4/7/2020
The speculations regarding using the corona virus as a weapon of bioterrorism can be used about diseases such as smallpox as well. Persistence market research report highlights the fact that though the smallpox is eradicated from the world, there are chances of an outbreak of this virus by mischievous intent of people closely associated with vaccinia virus stored in laboratories.
-
Pharmaceutical Supply Chain For Oral Vaccine Faces Challenges; COVID-19 to Generate Growth Opportunities, Says PMR
4/7/2020
The COVID-19 outbreak has created turbulence across the supply chain, taking a toll on the healthcare industry.
-
Hepatitis B Vaccine Market to Attain a Better Shape After COVID-19, Growing Awareness Will Drive Growth, Says PMR
4/7/2020
Growing awareness amongst the public and government is creating scope for vaccination of other diseases such as Hepatitis B. According to the PMR report, public awareness will play a vital role in the surge of hepatitis B vaccinations.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
-
After nearly five years at Alkermes, Lisa von Moltke has left the company and taken a new position as chief medical officer of Seres Therapeutics.
-
This Clinical Catch-Up has been split into three sections: COVID-19-Related Clinical Trials; Non-COVID-19-Related Clinical Trials; and Trials Affected by the COVID-19 Pandemic. Here’s a look.
-
Following close on the heels of its vaccine development agreement with China’s Xiamen Innovax Biotech, GlaxoSmithKline forged a research and development deal with Vir Biotechnology to develop treatments for COVID-19.
-
The research was presented at the Revolutionizing Atopic Dermatitis Virtual Symposium.
-
Empirical Bioscience’s 2019 RT-qPCR Kit Available For Use in nCoV Assay Testing
4/6/2020
Empirical Bioscience announced that their QuanTASE and QuanTASE PLUS One Step RT-qPCR RT-qPCR Kits have been successfully tested in assays using EUA authorized qPCR detection kits using the established CDC testing protocol.
-
GAC Beneficiary Houston Methodist Investigates Immunotherapy Techniques to Curb COVID-19
4/6/2020
Golfers Against Cancer takes pride in identifying research projects dedicated to specific work targeting various forms of cancer.
-
Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs
4/6/2020
Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Nina DeLorenzo to the position of senior vice president for global public affairs.
-
Theranica Expands Access to Prescribed Migraine Wearable Nerivio™ Through Partnership With UpScript Health Telemedicine Platform
4/6/2020
Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain conditions, today announced availability of Nerivio™ on UpScript's direct-to-patient telemedicine platform.